APA (7th ed.) Citation

V, N., CA, P., A, G., KJ, S. D., EC, L., LM, S., . . . JF, G. (2022). Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 12. https://doi.org/10.1200/JCO.21.01891

Chicago Style (17th ed.) Citation

V, Naranbhai, et al. "Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40, no. 1 (2022): 12. https://doi.org/10.1200/JCO.21.01891.

MLA (9th ed.) Citation

V, Naranbhai, et al. "Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 1, 2022, p. 12, https://doi.org/10.1200/JCO.21.01891.